-
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM -
Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Is the Biologics Price Competition and Innovation Act Working as Intended?
Mar 10, 2025, 14:00 PM -
Effects of Pre-existing Mental Health Disorders on Endocrine Therapy Adherence in Patients with Breast Cancer
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Reference and Biosimilar G-CSF As Primary Prophylaxis in DLBCL
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Automating Health Economic Model Quality Check With a Model Generator
Mar 10, 2025, 14:00 PM -
The Significance of Extracorporeal Removal Treatment in Paraquat Poisoning Patients: An Analysis of Plasma Paraquat Concentrations
Mar 10, 2025, 14:00 PM -
Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China
Mar 10, 2025, 14:00 PM -
Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population
Mar 10, 2025, 14:00 PM -
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fractures In Neurologically Intact Patients: A Cost-Utility Analysis
Mar 10, 2025, 14:00 PM -
Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study
Mar 10, 2025, 14:00 PM -
Extrapolation of Impact on Individual Patient Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD) Due to Relapse Reduction From Ravulizumab and Other Novel Biologic Treatments
Mar 10, 2025, 14:00 PM -
Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Mapping Disparities in Clinical Trial Enrollment Among HCC Patients: Insights From Social Determinants of Health
Mar 10, 2025, 14:00 PM -
Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?
Mar 10, 2025, 14:00 PM
